Clinical Trials
4 trialsNCT05920356 2026-06-04
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Amgen
Phase 3 Recruiting
NCT06497556 2026-04-20
Krascendo 1
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT05054725 2026-01-06
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
Phase 2 Completed
NCT04959981 2023-07-25
HERKULES-2
Erasca, Inc.
Phase 1 Completed